# Immuron Ltd: Form 20-F for the period ended Jun 30, 2022

- Company: [Immuron Ltd](/companies/imrn.md) (CIK 1660046)
- Form: 20-F
- Filed: 2022-09-09
- Accepted by EDGAR: Sep 9, 2022, 06:24 ET
- Period: 2022-06-30
- Accession: 0001213900-22-054904
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1660046/000121390022054904/f20f2022_immuronlimited.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1660046/000121390022054904/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Net income | 12 months, 2021-07-01 to 2022-06-30 | −AUD 2.9m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2021-07-01 to 2022-06-30 | −$1.25 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2021-07-01 to 2022-06-30 | −$1.25 | ifrs-full:BasicEarningsLossPerShare |
| Shares outstanding | at 2022-06-30 | 227,798,346 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1660046/000121390022054904/f20f2022_immuronlimited.htm

Filed Sep 9, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-054904. Last ingested by Listed: Oct 28, 2026, 08:01 ET. No prices; not investment advice.